Acadian Asset Management
FHTX icon

Acadian Asset Management’s Foghorn Therapeutics FHTX Stock Holding History

Acadian Asset Management’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$177K Buy
37,631
+29,905
+387% +$164K ﹤0.01% 1621
2025
Q4 		$41K Buy
+7,726
New +$35K ﹤0.01% 1823
2025
Q2 		– Sell
-9,495
Closed -$34K – 1709
2025
Q1 		$34K Sell
9,495
-26,289
-73% -$120K ﹤0.01% 1482
2024
Q4 		$168K Sell
35,784
-6,583
-16% -$48K ﹤0.01% 1283
2024
Q3 		$393K Hold
42,367
– – ﹤0.01% 1144
2024
Q2 		$243K Hold
42,367
– – ﹤0.01% 1381
2024
Q1 		$283K Buy
+42,367
New +$235K ﹤0.01% 1121
2023
Q2 		– Sell
-27,085
Closed -$165K – 1787
2023
Q1 		$165K Buy
27,085
+3,544
+15% +$23.2K ﹤0.01% 1296
2022
Q4 		$149K Buy
23,541
+19,181
+440% +$145K ﹤0.01% 1354
2022
Q3 		$37K Buy
+4,360
New +$56.1K ﹤0.01% 1534

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Acadian Asset Management's FHTX Position: Q1 2026 in Review

Acadian Asset Management increased its Foghorn Therapeutics (FHTX) stake by 387% in Q1 2026, buying an estimated $164K and bringing the position to 37,631 shares worth $177K. The position accounts for ﹤0.01% of the portfolio, ranked #1621.

Acadian Asset Management first reported a position in FHTX in Q3 2022 and has held it in 10 quarters since. The position peaked at $393K in Q3 2024. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Acadian Asset Management held 37,631 shares of Foghorn Therapeutics worth $177K as of Q1 2026.
  • Acadian Asset Management bought 29,905 Foghorn Therapeutics shares in Q1 2026, an estimated $164K.
  • Foghorn Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1621 holding.
  • Acadian Asset Management first reported a position in Foghorn Therapeutics in Q3 2022 and has held it in 10 quarters since.
  • Acadian Asset Management's Foghorn Therapeutics position peaked at $393K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.